Flyte Aviation, Inc. (VTAK)
NYSE American · Healthcare · Medical Devices
$0.151−0.66%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $287K
- 52-week range
- $0.13 – $3.20
- 52-week change
- −94.12%
- EPS (trailing)
- −$68.40
Fiscal year to Dec 2025
- Revenue
- $819K (+95.00%)
- Net income
- −$17.2M
- Operating margin
- −2581.6%
- Free cash flow
- −$8.3M
From the company’s annual report on SEC EDGAR.
About Flyte Aviation, Inc.
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
Headquarters: Fort Mill, United States · 17 employees · catheterprecision.com